Novo-Nordisk A/S

XNYS

Last traded price · USD

$41.57

−1.44%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 16:00 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $42.18
Volume: 315,129
Day's high: —
Day's low: —

In brief

Novo-Nordisk A/S is a US-listed company listed on the New York Stock Exchange, valued at about $183.36B.
Its shares closed at $42.18 on 4 Nov 2026, down 12.6% over the past year.
From India you can buy NVO in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Novo-Nordisk A/S (NVO) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole NVO share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade NVO options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Behind SPY over 1 year
1 month: +12.4% (SPY −1.6%). 3 months: −5.3% (SPY −0.4%). 1 year: −12.6% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: NVO, SPY · as of 4 Nov 2026
Above its 50-day average, below its 200-day
The 4 Nov 2026 close of $42.18 was 3.3% above its 50-day average ($40.84) and 3.9% below its 200-day average ($43.90). It has closed below the 200-day for 42 sessions, since 8 Sep 2026. The 50-day average crossed below the 200-day on 25 Sep 2026, 28 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
24% of the way up its 52-week range
Closed at $42.18 on 4 Nov 2026: 34.3% below the 52-week high of $64.16 (23 Jan 2026) and 20.1% above the low of $35.12 (30 Mar 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Volume 2.2× its 30-session average on 4 Nov 2026
4 Nov 2026 volume of 26.0M shares was 2.2× the average of the 30 sessions before it (11.7M), as the price rose 5.0%. SPY traded 1.5× its own average that session.
Daily volume against a 30-session baseline · as of 4 Nov 2026
Short interest at 1.1% of shares outstanding
37.4M shares were sold short at the 15 Oct 2026 settlement, 1.1% of the 3.39B shares outstanding; covering them would take 3.1 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+12.4%

6 months−7.8%

1 year−12.6%

5 years−27.2%

Newswire

About

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Website

Notable moves

July 29, 2025
−21.83%
December 20, 2024
−17.83%
August 8, 2023
+17.23%

Novo-Nordisk A/S

XNYS

Last traded price · USD

$41.57

−1.44%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 16:00 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $42.18
Volume: 315,129
Day's high: —
Day's low: —

In brief

Novo-Nordisk A/S is a US-listed company listed on the New York Stock Exchange, valued at about $183.36B.
Its shares closed at $42.18 on 4 Nov 2026, down 12.6% over the past year.
From India you can buy NVO in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Novo-Nordisk A/S (NVO) shares from India?

Do I need the price of a whole NVO share to invest?

How much can I invest in US stocks in a year?

Can I trade NVO options or futures?

Insights

Quotes run fifteen minutes behind.

Behind SPY over 1 year
1 month: +12.4% (SPY −1.6%). 3 months: −5.3% (SPY −0.4%). 1 year: −12.6% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: NVO, SPY · as of 4 Nov 2026
Above its 50-day average, below its 200-day
The 4 Nov 2026 close of $42.18 was 3.3% above its 50-day average ($40.84) and 3.9% below its 200-day average ($43.90). It has closed below the 200-day for 42 sessions, since 8 Sep 2026. The 50-day average crossed below the 200-day on 25 Sep 2026, 28 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
24% of the way up its 52-week range
Closed at $42.18 on 4 Nov 2026: 34.3% below the 52-week high of $64.16 (23 Jan 2026) and 20.1% above the low of $35.12 (30 Mar 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Volume 2.2× its 30-session average on 4 Nov 2026
4 Nov 2026 volume of 26.0M shares was 2.2× the average of the 30 sessions before it (11.7M), as the price rose 5.0%. SPY traded 1.5× its own average that session.
Daily volume against a 30-session baseline · as of 4 Nov 2026
Short interest at 1.1% of shares outstanding
37.4M shares were sold short at the 15 Oct 2026 settlement, 1.1% of the 3.39B shares outstanding; covering them would take 3.1 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+12.4%

6 months−7.8%

1 year−12.6%

5 years−27.2%

Newswire

About

Website

Notable moves

July 29, 2025
−21.83%
December 20, 2024
−17.83%
August 8, 2023
+17.23%

Novo-Nordisk A/S

Novo-Nordisk A/S in brief

Behind SPY over 1 year

Above its 50-day average, below its 200-day

24% of the way up its 52-week range

Volume 2.2× its 30-session average on 4 Nov 2026

Short interest at 1.1% of shares outstanding

Novo-Nordisk A/S

Novo-Nordisk A/S in brief

Behind SPY over 1 year

Above its 50-day average, below its 200-day

24% of the way up its 52-week range

Volume 2.2× its 30-session average on 4 Nov 2026

Short interest at 1.1% of shares outstanding